Expert insights on the use of long-acting injectables in schizophrenia
Long-acting injectables (LAIs) are commonly used in the treatment for schizophrenia.1 Administered via injection; their concentrated formulations release the antipsychotic drug slowly over time – allowing a maintenance dose of therapy to be delivered at intervals of 2 weeks to several months.1 Treatment with LAIs is associated with improved adherence, improved clinic
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now